GlaxoSmithKline

Biotech

GSK inks $1.3B biobucks deal for Mersana’s preclinical ADC

GSK has paid out $100 million cash to Mersana Therapeutics for the potential to add a second antibody-drug conjugate (ADC) to its pipeline.
Gabrielle Masson Aug 8, 2022 4:02pm

Roche taps new CEO—Chutes & Ladders

Jul 22, 2022 9:30am

Ex-GSK vaccine R&D chief to lead new vax venture, launch RSV jab

Jul 21, 2022 11:05am

Axel Hoos wants to reinvent small-molecule drugs at Scorpion

Jul 19, 2022 7:00am

Agios replaces CEO after recent FDA nod—Chutes & Ladders

Jul 15, 2022 9:30am

FDA shores up executive team with 2 hires—Chutes & Ladders

Jul 1, 2022 9:30am